153 related articles for article (PubMed ID: 36805049)
1. Diagnostic accuracy of the AGA, IAP, and European guidelines for detecting advanced neoplasia in intraductal papillary mucinous neoplasm/neoplasia.
van Huijgevoort NCM; Hoogenboom SAM; Lekkerkerker SJ; Busch OR; Del Chiaro M; Fockens P; Somers I; Verheij J; Voermans RP; Besselink MG; van Hooft JE
Pancreatology; 2023 Apr; 23(3):251-257. PubMed ID: 36805049
[TBL] [Abstract][Full Text] [Related]
2. Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome.
Lekkerkerker SJ; Besselink MG; Busch OR; Verheij J; Engelbrecht MR; Rauws EA; Fockens P; van Hooft JE
Gastrointest Endosc; 2017 May; 85(5):1025-1031. PubMed ID: 27693645
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
4. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.
Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K
Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110
[TBL] [Abstract][Full Text] [Related]
5. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
Distler M; Welsch T; Aust D; Weitz J; Grützmann R
Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
[TBL] [Abstract][Full Text] [Related]
6. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
[TBL] [Abstract][Full Text] [Related]
7. [Combination of intraductal papillary mucinous neoplasm with other cystic pancreatic tumors].
Panteleev VI; Kaldarov AR; Gorin DS; Kriger AG
Khirurgiia (Mosk); 2021; (2):80-83. PubMed ID: 33570359
[TBL] [Abstract][Full Text] [Related]
8. Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review.
Ohno E; Balduzzi A; Hijioka S; De Pastena M; Marchegiani G; Kato H; Takenaka M; Haba S; Salvia R
Pancreatology; 2024 Feb; 24(1):48-61. PubMed ID: 38161091
[TBL] [Abstract][Full Text] [Related]
9. Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria.
Sighinolfi M; Quan SY; Lee Y; Ibaseta A; Pham K; Dua MM; Poultsides GA; Visser BC; Norton JA; Park WG
Dig Dis Sci; 2017 Mar; 62(3):626-632. PubMed ID: 28116593
[TBL] [Abstract][Full Text] [Related]
10. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements.
Dbouk M; Brewer Gutierrez OI; Lennon AM; Chuidian M; Shin EJ; Kamel IR; Fishman EK; He J; Burkhart RA; Wolfgang CL; Hruban RH; Goggins MG; Canto MI
Pancreatology; 2021 Apr; 21(3):613-621. PubMed ID: 33593706
[TBL] [Abstract][Full Text] [Related]
11. [Cystic pancreatic lesions-indications, timing and reasons for surveillance].
Vornhülz M; Sirtl S; Orgler E; Weniger M; Schirra J; Beyer G; Mayerle J
Radiologie (Heidelb); 2023 Dec; 63(12):900-907. PubMed ID: 37878017
[TBL] [Abstract][Full Text] [Related]
12. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
[TBL] [Abstract][Full Text] [Related]
13. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.
Yoon WJ; Ryu JK; Lee JK; Woo SM; Lee SH; Park JK; Kim YT; Yoon YB
Ann Surg Oncol; 2008 Nov; 15(11):3193-8. PubMed ID: 18784959
[TBL] [Abstract][Full Text] [Related]
14. [Intraductal papillary mucinous neoplasia: which findings support observation?].
Mayerle J; Kraft M; Menges P; Simon P; Ringel J; Partecke LI; Heidecke CD; Lerch MM
Chirurg; 2012 Feb; 83(2):123-9. PubMed ID: 22271054
[TBL] [Abstract][Full Text] [Related]
15. European evidence-based guidelines on pancreatic cystic neoplasms.
European Study Group on Cystic Tumours of the Pancreas
Gut; 2018 May; 67(5):789-804. PubMed ID: 29574408
[TBL] [Abstract][Full Text] [Related]
16. The European evidence-based guidelines on pancreatic cystic neoplasms (PCN) in clinical practice: The development of relative and absolute indications for surgery during prospective IPMN surveillance.
Vaalavuo Y; Siiki A; Antila A; Rinta-Kiikka I; Sand J; Laukkarinen J
Pancreatology; 2020 Oct; 20(7):1393-1398. PubMed ID: 32938553
[TBL] [Abstract][Full Text] [Related]
17. [Intraductal papillary mucinous neoplasm of pancreas].
Panteleev VI; Gorin DS; Kaldarov AR; Kriger AG
Khirurgiia (Mosk); 2019; (11):81-87. PubMed ID: 31714535
[TBL] [Abstract][Full Text] [Related]
18. Comparing American Gastroenterological Association Pancreatic Cyst Management Guidelines with Fukuoka Consensus Guidelines as Predictors of Advanced Neoplasia in Patients with Suspected Pancreatic Cystic Neoplasms.
Ma GK; Goldberg DS; Thiruvengadam N; Chandrasekhara V; Kochman ML; Ginsberg GG; Vollmer CM; Ahmad NA
J Am Coll Surg; 2016 Nov; 223(5):729-737.e1. PubMed ID: 27497827
[TBL] [Abstract][Full Text] [Related]
19. Validation of the clinical utility of 4 guidelines in the initial triage of mucinous cystic lesions of the pancreas based on cross-sectional imaging: Experience with 188 surgically-treated patients.
Park RHS; Lim GRS; Wu JJY; Koh YX; Teo JY; Cheow PC; Chan CY; Ooi LLPJ; Chung AYF; Goh BKP
Eur J Surg Oncol; 2020 Nov; 46(11):2114-2121. PubMed ID: 32828582
[TBL] [Abstract][Full Text] [Related]
20. Optimal Surveillance Interval of Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas.
Han Y; Kwon W; Lee M; Jung HS; Yun WG; Cho YJ; Chae YS; Fernández-Del Castillo C; Marchegiani G; Salvia R; Goh BKP; Lee WJ; Jang JY
JAMA Surg; 2024 Apr; 159(4):389-396. PubMed ID: 38231494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
